Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

NCT01757171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastroesophageal Adenocarcinoma
Distal Esophageal Adenocarcinoma

Interventions

DRUG: Cabazitaxel

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]